Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Galderma launches phase 3 atopic dermatitis trial for nemolizumab Galderma, a Nestle-owned Swiss pharma company, said that it has enrolled the first patients in a phase 3… bypharmanewsdailyOctober 11, 2019
